Our unique team of experts brings together experience, passion and expertise.
LEADERSHIP
Nigel Theobald
Chairman of the Board
Nigel has over 25 years’ experience in healthcare and in building businesses, strategy development and its implementation and a strong network covering all aspects of pharmaceutical product development and commercialisation. He was the head of healthcare brands at Boots Group plc in 2002 before leaving to set up a series of successful businesses, including Oxford Pharmascience Group plc, which he grew over 5 years into an AIM quoted company with a market capitalisation of £40 million upon departure. Nigel formed N4 Pharma in 2014.
Paul Murray
Board Member
Paul is a chartered accountant with nearly 30 years of experience in the private equity market, having been a director of 3i PLC and a partner in Deutsche Bank’s private equity business. Paul now runs his own private equity fund.
Luke Cairns
Board Member
Luke has spent over 16 years working in corporate finance and is a former head of corporate finance and managing director at Northland Capital Partners, an FCA regulated stockbroking firm. Having left Northland in 2014, Luke founded LSC Advisory Limited to provide advisory and consultancy services to growth companies. He has worked with many growth companies across a number of sectors and regions on a wide range of transactions, including IPOs, secondary fundraisings, corporate restructurings and takeovers. He is an Associate of the Chartered Institute of Secretaries.
Scientific Advisory Board
Dr Yu-Wai-Man is a Group Leader and Assistant Professor at King's College, London. She developed the ECP-105 concept and is a Consultant Ophthalmic Surgeon with experience across in vitro and in vivo models, and in clinical trials in glaucoma.